Orphazyme: Top-line data in NPC looks promising
Research Note
2018-09-28
08:51
Orphazyme has reported top-line results for the NPC Phase II/III trial, showing a treatment benefit of arimoclomol over placebo at 12 months.
MS
Mathias Spinnars
Disclosures and disclaimers